Literature DB >> 9307113

Linear and nonlinear spectral integration in type IV neurons of the dorsal cochlear nucleus. I. Regions of linear interaction.

I Nelken1, E D Young.   

Abstract

The principal neurons of the dorsal cochlear nucleus have complex response properties, many of which are classified as type IV. These units integrate energy in the acoustic signal in a nonlinear fashion; for example, at high sound levels the response to a noise of narrow bandwidth and to a band-reject filtered noise with a spectral notch of the same bandwidth may both be inhibitory. However, the sum of these two stimuli, which is broadband noise (BBN), generally gives an excitatory response. In other situations, linear interactions among stimulus components are observed. In this paper, three regimes of approximate linearity were identified. First, best-frequency (BF) tones and equal-energy narrow noisebands centered at BF evoke almost the same response, which is consistent with a stage of linear filtering followed by a nonlinearity that generates the rate responses of the neuron. Second, for sounds close to threshold (10-15 dB re threshold), energy over the full bandwidth of the unit is integrated linearly. Within this regime, responses to the narrow noiseband and the spectral notch mentioned above do sum to equal the response to BBN. Finally, two noisebands centered at different frequencies, such that their sum is a notch in a broad band of noise, sum linearly at low sound levels; the degree of linearity improves as the separation between the noisebands increases. The results are interpreted in terms of a model of type IV response generation containing two inhibitory interneurons: type II units, which are active for narrowband stimuli, including tones, and the wideband inhibitor, which is active for broadband stimuli. In most cases, the onset of nonlinearity occurs for stimuli that significantly activate the type II inhibitory interneuron.

Entities:  

Mesh:

Year:  1997        PMID: 9307113     DOI: 10.1152/jn.1997.78.2.790

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  9 in total

1.  Linear and nonlinear pathways of spectral information transmission in the cochlear nucleus.

Authors:  J J Yu; E D Young
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Bidirectional synaptic plasticity in the cerebellum-like mammalian dorsal cochlear nucleus.

Authors:  Kiyohiro Fujino; Donata Oertel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-16       Impact factor: 11.205

Review 3.  Discriminating among complex signals: the roles of inhibition for creating response selectivities.

Authors:  George D Pollak
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2010-11-03       Impact factor: 1.836

4.  Nonlinear temporal receptive fields of neurons in the dorsal cochlear nucleus.

Authors:  Sharba Bandyopadhyay; Eric D Young
Journal:  J Neurophysiol       Date:  2013-08-28       Impact factor: 2.714

5.  Temporal and binaural properties in dorsal cochlear nucleus and its output tract.

Authors:  P X Joris; P H Smith
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

6.  Dorsal Cochlear Nucleus of the Rat: Representation of Complex Sounds in Ears Damaged by Acoustic Trauma.

Authors:  Yang Li; Tessa-Jonne F Ropp; Bradford J May; Eric D Young
Journal:  J Assoc Res Otolaryngol       Date:  2015-05-13

Review 7.  Listening to another sense: somatosensory integration in the auditory system.

Authors:  Calvin Wu; Roxana A Stefanescu; David T Martel; Susan E Shore
Journal:  Cell Tissue Res       Date:  2014-12-21       Impact factor: 5.249

8.  Rate-level responses in awake marmoset auditory cortex.

Authors:  Paul V Watkins; Dennis L Barbour
Journal:  Hear Res       Date:  2010-12-09       Impact factor: 3.208

9.  Contralateral effects and binaural interactions in dorsal cochlear nucleus.

Authors:  Kevin A Davis
Journal:  J Assoc Res Otolaryngol       Date:  2005-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.